Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
Clinical trial NCT03569514 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03569514
- Sponsor
- Emergent BioSolutions
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-11-30
- Primary completion
- 2027-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.